JiangXi Tianxin Pharmaceutical Co., Ltd.SSE: 603235

(603235)"JIANGXI TIANXIN PHARMACEUTICAL CO., LTD."Report for Q3 2026

· Issued by JiangXi Tianxin Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 603235 · · 20 pages · Chinese

Summary by 6ix AI

The report confirms the accuracy and completeness of the financial information provided, with no audit conducted for the quarter. Key financial data includes revenue and net profit figures, which reflect changes compared to the previous year.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/603235jiangxi-tianxin-pharmaceutical-co-ltdreport-for-q3-2026

JiangXi Tianxin Pharmaceutical Co., Ltd. on 6ix

Earlier from JiangXi Tianxin Pharmaceutical

All JiangXi Tianxin Pharmaceutical news releases